Alastair Mathewson
3PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 02, 2026
Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study.John F R Robertson, Teimuraz Gogitidze, Zaza Katashvili
|Jan 21, 2026
Open-Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women.Andy Sykes, Helena Engman, Nigel Taylor
|Aug 11, 2025
Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.Richard D Baird, Begoña Bermejo de Las Heras, Manuel Ruiz-Borrego
Pageof 1
Frequent Collaborators
3 joint publications
Justin P O Lindemann
2 joint publications
Andy Sykes
2 joint publications
Christopher J Morrow
2 joint publications
Teresa Klinowska
1 joint publications
Begoña Bermejo de Las Heras
1 joint publications
Manuel Ruiz-Borrego
1 joint publications
Kwok-Leung Cheung
1 joint publications
Irene Moreno
1 joint publications
Mafalda Oliveira
1 joint publications
Nicholas Turner
